Anti-CD20 Monoclonal Antibody as a New Treatment Modality for B-Cell Lymphoma
スポンサーリンク
概要
- 論文の詳細を見る
Patients with follicular non-Hodgkin's lymphoma (NHL) generally have an indolent clinical course and respond wellto standard chemotherapeutic regimens. However, the response duration is rather short. There has been no therapeutic regimen superior to CHOP chemotherapy for aggressive NHL in past 20 years. Novel therapeutic strategies are necessary for these types of B-cell lymphomas which express CD20 antigen on the surface of tumor cells. Chimeric human / mouse anti-CD20 monoclonal antibody, rituximab, has a powerful therapeutic activity with minimal adverse reaction in B-cell lymphoma through complement-dependent cytotoxicity(CDC) or antibody-dependent cell-mediated cytotoxicity(ADCC) and apoptotic mechanisms. The combination of rituximab and CHOP chemotherapy produced a high response rate(95%) in patients with indolent B-cell NHL and prolonged the progression-free and overall survivals in patients with diffuse large-B-cell lymphoma. Confirmation of CD20 expression of tumor cells is essential to predict the response to rituximab in B-cell lymphoma.
- 日本組織細胞化学会の論文
著者
-
HOTTA Tomomitsu
Division of Hematology and Rheumatology, Tokai University School of Medicine
-
Hotta T
Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine
関連論文
- Ciliates rapidly enhance the frequency of conjugation between Escherichia coli strains through bacterial accumulation in vesicles
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- In Vitro Antibacterial Activity of Phx-3 against Helicobacter pylori
- Effect of Helicobacter pylori on DNA synthesis of human epithelial cells
- Growth Inhibition of Helicobacter pylori by Monoclonal Antibody to Heat-Shock Protein 60
- Analysis of the Epitopes Recognized by Mouse Monoclonal Antibodies Directed to Yersinia enterocolitica Heat-Shock Protein 60
- Phenoxazine Compounds Produced by the Reactions with Bovine Hemoglobin Show Antimicrobial Activity Against Non-tuberculosis Mycobacteria
- Effect of probiotic bacterial strains of Lactobacillus, Bifidobacterium, and Enterococcus on enteroaggregative Escherichia coli
- Mutual correlation between gastric flora and Helicobacter pylori in gastric mucosa of Mongolian gerbil (第43回 日本無菌生物ノートバイオロジー学会総会)
- Anti-CD20 Monoclonal Antibody as a New Treatment Modality for B-Cell Lymphoma
- Anti-CD20 Monoclonal Antibody as New Treatment Modality for B-Cell Lymphoma
- Effect of the steroid receptor antagonist RU486 (mifepristone) on an IFNγ-induced persistent Chlamydophila pneumoniae infection model in epithelial HEp-2 cells
- Ciliates promote the transfer of the gene encoding the extended-spectrum -lactamase CTX-M-27 between Escherichia coli strains
- In vitro and in vivo effects of the Mongolian drug Amu-ru 7 on Helicobacter pylori growth and viability
- Inhibition of cytotoxicity of Clostridium difficile in co-culture with C. butyricum MIYAIRI 588 strain in the absence of growth inhibition
- Effect of the steroid receptor antagonist RU486 (mifepristone) on an IFNγ-induced persistent Chlamydophila pneumoniae infection model in epithelial HEp-2 cells